Published in ACS Nano on February 23, 2010
Isolation and characterization of dendrimers with precise numbers of functional groups. Chemistry (2010) 1.11
Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation. Acc Chem Res (2011) 1.00
Best practices for purification and characterization of PAMAM dendrimer. Macromolecules (2012) 0.98
Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv (2013) 0.96
Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic. Mol Pharm (2012) 0.92
Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting. Eur J Med Chem (2011) 0.91
Isolation and characterization of precise dye/dendrimer ratios. Chemistry (2014) 0.88
PAMAM Dendrimers as Quantized Building Blocks for Novel Nanostructures. Soft Matter (2013) 0.88
Avidity mechanism of dendrimer-folic acid conjugates. Mol Pharm (2014) 0.86
Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform. Bioconjug Chem (2011) 0.86
Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct. Mol Pharm (2010) 0.86
Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry. Mol Pharm (2013) 0.84
Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery. Int J Mol Sci (2015) 0.84
Fluorophore:dendrimer ratio impacts cellular uptake and intracellular fluorescence lifetime. Bioconjug Chem (2015) 0.82
Design and Evaluation of Tumor-Specific Dendrimer Epigenetic Therapeutics. ChemistryOpen (2015) 0.80
Light-scattering detection below the level of single fluorescent molecules for high-resolution characterization of functional nanoparticles. ACS Nano (2014) 0.80
Multivalent polymers for drug delivery and imaging: the challenges of conjugation. Biomacromolecules (2014) 0.80
Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic. Curr Pharm Des (2013) 0.80
Plasmonic Nanoparticles with Quantitatively Controlled Bioconjugation for Photoacoustic Imaging of Live Cancer Cells. Adv Sci (Weinh) (2016) 0.79
Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery. Biomacromolecules (2012) 0.78
Light-controlled active release of photocaged ciprofloxacin for lipopolysaccharide-targeted drug delivery using dendrimer conjugates. Chem Commun (Camb) (2016) 0.77
Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding protein. Mol Pharm (2014) 0.77
Generation 3 PAMAM dendrimer TAMRA conjugates containing precise dye/dendrimer ratios. Mater Today (Kidlington) (2015) 0.77
Facet-specific assembly of proteins on SrTiO₃ polyhedral nanocrystals. Sci Rep (2014) 0.75
Rapid Exchange Between Free and Bound States in RNA-Dendrimer Polyplexes: Implications on the Mechanism of Delivery and Release. Biomacromolecules (2015) 0.75
Dendrimer antibody conjugate to target and image HER-2 overexpressing cancer cells. Oncotarget (2016) 0.75
Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting. J Drug Target (2015) 0.75
Differentiation of Functional Groups and Biologically Relevant Anions Using AT-PAMAM Dendrimers. Supramol Chem (2013) 0.75
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Designing dendrimers for biological applications. Nat Biotechnol (2005) 4.92
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res (2005) 4.71
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem (1999) 4.41
Array-based electrical detection of DNA with nanoparticle probes. Science (2002) 4.33
Nanotechnology applications in cancer. Annu Rev Biomed Eng (2007) 3.88
Dendrimers in biomedical applications--reflections on the field. Adv Drug Deliv Rev (2005) 3.39
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol (2007) 3.36
Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc (2007) 2.60
A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res (2003) 2.55
Dendrimers and dendritic polymers in drug delivery. Drug Discov Today (2005) 2.37
Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem (2005) 2.32
Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem (2007) 2.31
Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res (2002) 2.30
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules (2006) 2.17
Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem Biol (2005) 2.05
Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem (2005) 1.80
Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol (2002) 1.77
Isolation of discrete nanoparticle-DNA conjugates for plasmonic applications. Nano Lett (2008) 1.59
Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates. Chem Commun (Camb) (2005) 1.58
Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta (2005) 1.58
Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem (2008) 1.52
Therapeutic and diagnostic applications of dendrimers for cancer treatment. Adv Drug Deliv Rev (2008) 1.35
Solution-phase single quantum dot fluorescence resonance energy transfer. J Am Chem Soc (2006) 1.32
Multivalent, bifunctional dendrimers prepared by click chemistry. Chem Commun (Camb) (2005) 1.32
Counting the number of proteins coupled to single nanoparticles. J Am Chem Soc (2007) 1.25
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. Bioconjug Chem (2004) 1.24
Nanocarriers: promising vehicle for bioactive drugs. Biol Pharm Bull (2006) 1.23
Biological applications of dendrimers. Curr Opin Chem Biol (2002) 1.22
Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers. ACS Nano (2008) 1.22
Structure and function of nanoparticle-protein conjugates. Biomed Mater (2008) 1.18
Poly(ethylene glycol) ligands for high-resolution nanoparticle mass spectrometry. J Am Chem Soc (2007) 1.07
The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. Biomaterials (2006) 1.07
Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures. Bioconjug Chem (2007) 1.06
Surface-functionalized nanoparticle library yields probes for apoptotic cells. Chembiochem (2004) 1.05
Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging. Bioconjug Chem (1996) 1.05
Folate-receptor-targeted radionuclide imaging agents. Adv Drug Deliv Rev (2004) 1.04
Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther (2002) 1.02
The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles. Bioconjug Chem (2008) 1.00
Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjug Chem (2004) 0.99
Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates. Anticancer Drugs (2008) 0.97
Synthesis of methotrexate-antibody conjugates by regiospecific coupling and assessment of drug and antitumor activities. J Med Chem (1989) 0.96
HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein. Analyst (2006) 0.92
Dendrimer-based BH3 conjugate that targets human carcinoma cells. Biomacromolecules (2007) 0.92
Synthesis and protein binding properties of T-antigen containing GlycoPAMAM dendrimers. Bioorg Med Chem (2002) 0.85
Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery. J Biomed Mater Res A (2007) 0.84
Gadolinium texaphyrin-methotrexate conjugates. Towards improved cancer chemotherapeutic agents. Org Biomol Chem (2005) 0.81
Resolving the structure of ligands bound to the surface of superparamagnetic iron oxide nanoparticles by high-resolution magic-angle spinning NMR spectroscopy. J Am Chem Soc (2008) 0.81
Synthesis of oligotuftsin-based branched oligopeptide conjugates for chemotactic drug targeting. J Pept Sci (2006) 0.78
Mechanistic analysis of macrophage response to IRAK-1 gene knockdown by a smart polymer-antisense oligonucleotide therapeutic. J Biomater Sci Polym Ed (2008) 0.77
Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies. Mol Pharmacol (1985) 0.76
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res (2005) 4.71
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol (2007) 3.36
Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem (2006) 2.87
Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug Chem (2004) 2.66
Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Acc Chem Res (2007) 2.34
Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J Med Chem (2005) 2.32
Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res (2002) 2.30
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules (2006) 2.17
Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem Biol (2005) 2.05
Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev (2005) 1.97
Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett (2008) 1.96
Protein modification, bioconjugation, and disulfide bridging using bromomaleimides. J Am Chem Soc (2010) 1.89
Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. Biophys J (2005) 1.81
Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem (2005) 1.80
Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol (2002) 1.77
Applications of nanotechnology for immunology. Nat Rev Immunol (2013) 1.65
Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate (2007) 1.56
Lipid bilayer disruption by polycationic polymers: the roles of size and chemical functional group. Langmuir (2005) 1.56
Effects of a dental adhesive incorporating antibacterial monomer on the growth, adherence and membrane integrity of Streptococcus mutans. J Dent (2009) 1.46
Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small (2007) 1.45
Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem Phys Lipids (2004) 1.42
Bromomaleimides: new reagents for the selective and reversible modification of cysteine. Chem Commun (Camb) (2009) 1.40
Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis. Chem Commun (Camb) (2011) 1.38
Pre-event smallpox vaccination and postevent exposure and disease: a report of the Joint Task Force on Smallpox Vaccination for Allergists. Ann Allergy Asthma Immunol (2005) 1.38
CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One (2008) 1.36
HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjug Chem (2006) 1.36
In situ maleimide bridging of disulfides and a new approach to protein PEGylation. Bioconjug Chem (2011) 1.33
Dendrimer-epidermal growth factor conjugate displays superagonist activity. Biomacromolecules (2008) 1.31
CBP/p300 are bimodal regulators of Wnt signaling. EMBO J (2007) 1.31
Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement. Int J Nanomedicine (2008) 1.28
Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge. Infect Immun (2007) 1.27
Cationic nanoparticles induce nanoscale disruption in living cell plasma membranes. J Phys Chem B (2009) 1.27
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. Bioconjug Chem (2004) 1.24
Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers. ACS Nano (2008) 1.22
Distribution of type I collagen morphologies in bone: relation to estrogen depletion. Bone (2009) 1.22
The role of apoptosis in thyroid autoimmunity. Thyroid (2007) 1.20
Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS One (2008) 1.20
Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Phys Chem Chem Phys (2007) 1.20
Game-based exercises for dynamic short-sitting balance rehabilitation of people with chronic spinal cord and traumatic brain injuries. Phys Ther (2007) 1.18
Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates. AIDS Res Hum Retroviruses (2008) 1.18
Strong exchange and magnetic blocking in N₂³⁻-radical-bridged lanthanide complexes. Nat Chem (2011) 1.18
Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion. Vaccine (2003) 1.17
Real-time biomolecular binding detection using a sensitive photonic crystal biosensor. Anal Chem (2010) 1.17
Task-specific rehabilitation of finger-hand function using interactive computer gaming. Arch Phys Med Rehabil (2008) 1.16
Type I collagen exists as a distribution of nanoscale morphologies in teeth, bones, and tendons. Langmuir (2010) 1.15
Bromopyridazinedione-mediated protein and peptide bioconjugation. Chem Commun (Camb) (2011) 1.15
Current dendrimer applications in cancer diagnosis and therapy. Curr Top Med Chem (2008) 1.14
Sensitive molecular binding assay using a photonic crystal structure in total internal reflection. Opt Express (2008) 1.14
Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett (2005) 1.13
Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers. Langmuir (2005) 1.13
In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles. Biomacromolecules (2004) 1.13
Two-photon fluorescence correlation spectroscopy through a dual-clad optical fiber. Opt Express (2008) 1.12
Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab Invest (2004) 1.12
Isolation and characterization of dendrimers with precise numbers of functional groups. Chemistry (2010) 1.11
Poly(amidoamine) dendrimers on lipid bilayers II: Effects of bilayer phase and dendrimer termination. J Phys Chem B (2008) 1.10
Bromomaleimide-linked bioconjugates are cleavable in mammalian cells. Chembiochem (2011) 1.09
Collision and violation involvement of drivers who use cellular telephones. Traffic Inj Prev (2003) 1.09
Nanoscale morphology of Type I collagen is altered in the Brtl mouse model of Osteogenesis Imperfecta. J Struct Biol (2010) 1.08
HPLC analysis of PAMAM dendrimer based multifunctional devices. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.07
Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant. Crit Rev Immunol (2010) 1.07
Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212. PLoS One (2013) 1.07
Structure determination and characterization of two rare-earth molybdenum borate compounds: LnMoBO(6) (Ln = La, Ce). Dalton Trans (2008) 1.06
Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures. Bioconjug Chem (2007) 1.06
Closing the gap between interdisciplinary research and disciplinary teaching. ACS Chem Biol (2007) 1.06
Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers. Mol Pharm (2012) 1.06
The role of ganglioside GM1 in cellular internalization mechanisms of poly(amidoamine) dendrimers. Bioconjug Chem (2009) 1.05
Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate. Chem Commun (Camb) (2010) 1.04
A novel, killed-virus nasal vaccinia virus vaccine. Clin Vaccine Immunol (2007) 1.03
Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells. Biomacromolecules (2007) 1.03
Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis Rheum (2011) 1.03
Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations. Biomacromolecules (2009) 1.03
Isolation of dysprosium and yttrium complexes of a three-electron reduction product in the activation of dinitrogen, the (N2)3- radical. J Am Chem Soc (2009) 1.02
Poly(amidoamine) dendrimers on lipid bilayers I: Free energy and conformation of binding. J Phys Chem B (2008) 1.02
A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease. PLoS One (2011) 1.02
In Vivo Monitoring of Multiple Circulating Cell Populations Using Two-photon Flow Cytometry. Opt Commun (2008) 1.02
Mutant mice lacking the p53 C-terminal domain model telomere syndromes. Cell Rep (2013) 1.02